Compounded drugs containing the same active ingredient arent always the same because two patients may have different needs, resulting in various formulations
Not to mention the ads I see them on the New York City subway, on Instagram (RIP my algorithm for researching this story), and, well, everywhere else
For a less expensive, more comprehensive GLP-1 program with long-term support, see our Shed review here
This is perfect for those seeking to assist clients on GLP-1 drugs
Exenatide, a GLP-1 agonist sold under the brand names Byetta and Bydureon by AstraZeneca (LSE: AZN) as a type 2 diabetes drug, could be useful in another indication, a trial has found